Potentiation of the Antibacterial Effect of Methanamine by Acetohydroxamic Acid
- 1 February 1974
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 5 (2) , 101-105
- https://doi.org/10.1128/aac.5.2.101
Abstract
In vitro testing shows nearly all strains of Proteus to be susceptible to methenamine. However, infection by urease-producing bacteria alkalinizes the urine in vivo and prevents generation of formaldehyde, the active metabolite, from methenamine. We have previously shown acetohydroxamic acid (AHA) to be an effective inhibitor of bacterial urease in vitro and in vivo. We now present data obtained by use of static and dynamic in vitro systems, which show that, by preventing urease-induced alkalinization of urine, AHA enables methenamine to exert its antibacterial effect against representative Proteus species.Keywords
This publication has 12 references indexed in Scilit:
- Interaction Between Acetohydroxamic Acid and 12 Antibiotics Against 14 Gram-Negative Pathogenic BacteriaAntimicrobial Agents and Chemotherapy, 1974
- Inhibition of bacterial urease.1973
- Prevention of infected urinary stones by urease inhibition.1973
- Ammonia Production in the Human ColonNew England Journal of Medicine, 1970
- Urinary concentrating ability in early experimental pyelonephritisJournal of Clinical Investigation, 1970
- RELATION BETWEEN RESIDUAL URINE VOLUME AND RESPONSE TO TREATMENT OF URINARY INFECTIONThe Lancet, 1970
- Preparation and some properties of stable and carbon-14 and tritium-labeled short-chain aliphatic hydroxamic acidsAnalytical Biochemistry, 1969
- Antibacterial activity of human urineJournal of Clinical Investigation, 1968
- Activity products in stone-forming and non-stone-forming urine.1968
- Effects of Urease Inhibition in Hyperammonemia: Clinical and Experimental Studies with Acetohydroxamic AcidGastroenterology, 1968